查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1871311

骨缺损填充材料市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

Bone Void Fillers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球骨缺损填充物市场价值为 36 亿美元，预计到 2034 年将以 6.9% 的复合年增长率增长至 70 亿美元。

骨填充剂市场 - IMG1

骨科和创伤手术数量的增加以及骨折、骨质疏鬆等骨骼相关疾病盛行率的上升推动了市场扩张。一个主要趋势是从传统的自体骨移植和异体骨移植转向合成和生物活性骨填充材料，包括磷酸钙、生物活性玻璃和复合支架。这些替代材料具有可预测的吸收率、更低的感染风险和更优异的生物相容性，使其成为广泛临床应用的理想选择。注射式骨填充材料的需求也不断增长，因为它们有助于微创手术、缩短手术时间并改善患者復原。全球预期寿命的延长、城市化进程的加快以及退化性骨骼疾病和创伤相关损伤发病率的上升进一步推动了市场成长，尤其是在已开发地区和新兴地区。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 36亿美元
预测值 70亿美元
复合年增长率 6.9%

2024年，脱矿骨基质（DBM）市占率为36.1%，预计2025年至2034年间将以6.1%的复合年增长率成长。 DBM因其高骨诱导潜能、良好的生物相容性和临床应用的多样性而备受青睐。 DBM源自于加工后的同种异体骨，保留了胶原蛋白、骨形态发生蛋白和生长因子等关键有机成分，这些成分能够促进新骨形成和有效的移植物整合。 DBM有多种给药形式，例如糊状物、膏状物、凝胶和条状物，使外科医生在骨科、创伤和脊椎融合手术中能够灵活选择。

2024年，骨糊剂市场规模达到15亿美元，预计2034年将以7.2%的复合年增长率成长。外科医生偏爱骨糊剂，因为它具有良好的黏性和可塑性，能够精准地填充不规则或复杂的骨缺损。其优异的操作性和适应性使其成为脊椎融合、颅颜重建、骨科创伤和牙科手术的理想选择。

2024年，北美骨填充剂市占率达到48.9%。该地区受益于先进的医疗基础设施、庞大的手术量，以及许多提供微创解决方案和创新骨移植替代材料的领导者。生物活性注射填充剂的早期应用，以及对研发和临床试验的大量投入，巩固了北美在该领域的领先地位。

全球骨填充材料市场的主要企业包括Arthrex、Bioventus、Medline、Medtronic、Abyrx、Stryker、Baxter International、DePuy Synthes（强生）、Bonesupport、Acumed和Zimmer Biomet。这些企业正透过策略措施提升自身在骨填充材料市场的份额。他们加大研发投入，致力于推出具有卓越骨诱导性、吸收率和生物相容性的先进生物材料。与医院、手术中心和经销商建立合作关係有助于扩大市场覆盖范围，并提高创新产品的市场接受度。併购则用于增强技术实力和扩大生产规模。此外，各企业也专注于获得监管部门的批准、产品认证和开展临床试验，以提升自身信誉。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

  • 产业生态系分析
  • 产业影响因素
    • 成长驱动因素
      • 骨骼疾病和损伤的发生率不断上升
      • 老年人口增长
      • 外科技术的进步
      • 骨科手术日益增多
    • 产业陷阱与挑战
      • 骨骼疾病治疗费用高昂
      • 严格的监管环境
    • 市场机会
      • 转向微创和注射解决方案
      • 生物活性和抗生素洗脱填充剂的进展
  • 成长潜力分析
  • 技术格局
    • 当前技术趋势
    • 新兴技术
  • 监管环境
    • 北美洲
    • 欧洲
    • 亚太地区
  • 未来市场趋势
  • 波特的分析
  • PESTEL 分析

第四章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 关键进展
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章：市场估算与预测：依材料类型划分，2021-2034年

  • 主要趋势
  • 去矿骨基质
  • 硫酸钙
  • 胶原蛋白基质
  • 磷酸三钙/磷酸钙基
  • 其他材料类型

第六章：市场估算与预测：依形式划分，2021-2034年

  • 主要趋势
  • 凝胶
  • 颗粒
  • 膏剂/注射剂
  • 油灰
  • 其他形式

第七章：市场估计与预测：依应用领域划分，2021-2034年

  • 主要趋势
  • 脊椎融合术
  • 骨折
  • 关节重建
  • 牙科/颅颜面外科（CMF）
  • 其他应用

第八章：市场估算与预测：依最终用途划分，2021-2034年

  • 主要趋势
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 其他最终用途

第九章：市场估计与预测：依地区划分，2021-2034年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第十章：公司简介

  • Abyrx
  • Acumed
  • Arthrex
  • Baxter International
  • Bioventus
  • Bonesupport
  • DePuy Synthes (Johnson & Johnson)
  • Medline
  • Medtronic
  • Stryker
  • Zimmer Biomet
简介目录
Product Code: 8861

The Global Bone Void Fillers Market was valued at USD 3.6 billion in 2024 and is estimated to grow at a CAGR of 6.9% to reach USD 7 billion by 2034.

Bone Void Fillers Market - IMG1

The market expansion is fueled by the rising number of orthopedic and trauma surgeries and the increasing prevalence of bone-related conditions, such as fractures and osteoporosis. A major trend is the shift from conventional autografts and allografts to synthetic and bioactive bone void fillers, including calcium phosphate, bioactive glass, and composite scaffolds. These alternatives provide predictable resorption rates, lower infection risks, and superior biocompatibility, making them ideal for widespread clinical use. The demand for injectable bone void fillers is also increasing, as they facilitate minimally invasive procedures, reduce surgical time, and improve patient recovery. Rising global life expectancy, urbanization, and the growing incidence of degenerative skeletal diseases and trauma-related injuries are further driving market growth, especially across both developed and emerging regions.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$3.6 Billion
Forecast Value$7 Billion
CAGR6.9%

The demineralized bone matrix (DBM) segment held a 36.1% share in 2024 and is projected to grow at a CAGR of 6.1% during 2025-2034. DBM is favored for its high osteoinductive potential, biocompatibility, and versatility in clinical applications. Derived from processed allograft bone, DBM retains key organic components, including collagen, bone morphogenetic proteins, and growth factors, which promote new bone formation and effective graft integration. Available in multiple delivery formats, such as putty, paste, gel, and strips, it allows surgeons flexibility in orthopedic, trauma, and spinal fusion procedures.

The putty segment generated USD 1.5 billion in 2024 and is expected to grow at a CAGR of 7.2% through 2034. Surgeons prefer putty due to its cohesive, moldable texture, which allows precise placement in irregular or complex bone defects. Its superior handling and adaptability make it ideal for applications in spinal fusion, craniofacial reconstruction, orthopedic trauma, and dental surgeries.

North America Bone Void Fillers Market held a 48.9% share in 2024. The region benefits from advanced healthcare infrastructure, high surgical volumes, and the presence of leading players offering minimally invasive solutions and innovative bone graft substitutes. Early adoption of bioactive and injectable fillers, along with significant investment in R&D and clinical trials, has reinforced North America's leadership in this sector.

Key companies operating in the Global Bone Void Fillers Market include Arthrex, Bioventus, Medline, Medtronic, Abyrx, Stryker, Baxter International, DePuy Synthes (Johnson & Johnson), Bonesupport, Acumed, and Zimmer Biomet. Companies in the Bone Void Fillers Market are enhancing their presence through strategic initiatives. They are investing in research and development to introduce advanced biomaterials with superior osteoinductivity, resorption rates, and biocompatibility. Partnerships and collaborations with hospitals, surgical centers, and distributors help expand market reach and improve adoption of innovative products. Mergers and acquisitions are used to strengthen technological capabilities and scale production. Firms are also focusing on regulatory approvals, product certifications, and clinical trials to enhance credibility.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Material type trends
    • 2.2.3 Form trends
    • 2.2.4 Application trends
    • 2.2.5 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of bone disorders and injuries
      • 3.2.1.2 Rise in geriatric population
      • 3.2.1.3 Advancements in surgical techniques
      • 3.2.1.4 Growing orthopedic surgeries
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with bone disorders
      • 3.2.2.2 Stringent regulatory scenario
    • 3.2.3 Market opportunities
      • 3.2.3.1 Shift toward minimally invasive and injectable solutions
      • 3.2.3.2 Advancement in bioactive and antibiotic-eluting fillers
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
    • 3.4.1 Current technological trends
    • 3.4.2 Emerging technologies
  • 3.5 Regulatory landscape
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Asia Pacific
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Merger and acquisition
    • 4.6.2 Partnership and collaboration
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Material Type, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Demineralized bone matrix
  • 5.3 Calcium sulfate
  • 5.4 Collagen matrix
  • 5.5 Tricalcium phosphate/calcium phosphate based
  • 5.6 Other material types

Chapter 6 Market Estimates and Forecast, By Form, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Gel
  • 6.3 Granules
  • 6.4 Paste / injectable
  • 6.5 Putty
  • 6.6 Other forms

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Spine fusion
  • 7.3 Bone fracture
  • 7.4 Joint reconstruction
  • 7.5 Dental / cranio-maxillofacial surgery (CMF)
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Specialty clinics
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Abyrx
  • 10.2 Acumed
  • 10.3 Arthrex
  • 10.4 Baxter International
  • 10.5 Bioventus
  • 10.6 Bonesupport
  • 10.7 DePuy Synthes (Johnson & Johnson)
  • 10.8 Medline
  • 10.9 Medtronic
  • 10.10 Stryker
  • 10.11 Zimmer Biomet